8-KThe WireRed Alert
Executive Change · Shareholder Vote
Filed Jun 9, 2026 · 24d ago · Accession 0000886163-26-000038
Plain English
Ligand Pharmaceuticals Incorporated held its 2026 Annual Meeting of Stockholders on June 5, 2026, where stockholders elected directors, ratified the selection of its independent auditor, approved executive compensation, and approved an amendment and restatement of the 2002 Stock Incentive Plan.
Filing details
- Company
- LIGAND PHARMACEUTICALS INC
- Ticker
- LGND
- CIK
- 886163
- Form type
- 8-K
- Filing date
- Jun 9, 2026
- Report date
- Jun 5, 2026
- Document
- lgnd-20260605.htm
- Size
- 160 KB